While subjected to Rucaparib treatment, overexpression of HORMAD1 in the HCC1954 model reduced tumor sensitivity to Rucaparib treatment (Figure 4), which is consistent with our analyses of cell line data (Figure 3). The gene discussed is HORMAD1; the disease is neoplasm.